Coherus Oncology (CHRS) Total Non-Current Liabilities (2013 - 2026)
Coherus Oncology's Total Non-Current Liabilities was $112.76 million in Q2 2026, down 62.8% from $302.9 million a year earlier and down 33.8% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Total Non-Current Liabilities at Coherus Oncology came in at $177.44 million, down 67.8% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of -20.5% (FY2020 to FY2025).
- In earlier years, Total Non-Current Liabilities was $551.19 million in FY2024 (-32.0%), $810.47 million in FY2023 (+31.8%), $614.8 million in FY2022 (+5.8%) and $580.86 million in FY2021 (+3.8%).
- The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2013.
- Compared with a year earlier, Total Non-Current Liabilities has declined for eight straight quarters, with an average decline of 46.8% over the last eight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2024 (growth of 40.7%); the worst was Q4 2025 (a decline of 67.8%).
- Per Business Quant data, CHRS's Total Non-Current Liabilities in the three quarters before Q2 2026 was $170.43 million (Q1 2026), $177.44 million (Q4 2025) and $411.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 112.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.76 Mn |
| Mar 31, 2026 | 170.43 Mn |
| Dec 31, 2025 | 177.44 Mn |
| Sep 30, 2025 | 411.20 Mn |
| Jun 30, 2025 | 302.90 Mn |
| Mar 31, 2025 | 523.25 Mn |
| Dec 31, 2024 | 551.19 Mn |
| Sep 30, 2024 | 563.81 Mn |
| Jun 30, 2024 | 731.27 Mn |
| Mar 31, 2024 | 842.66 Mn |
| Dec 31, 2023 | 810.47 Mn |
| Sep 30, 2023 | 713.87 Mn |
| Jun 30, 2023 | 644.25 Mn |
| Mar 31, 2023 | 598.83 Mn |
| Dec 31, 2022 | 614.80 Mn |
| Sep 30, 2022 | 647.94 Mn |
| Jun 30, 2022 | 568.53 Mn |
| Mar 31, 2022 | 580.72 Mn |
| Dec 31, 2021 | 580.86 Mn |
| Sep 30, 2021 | 610.22 Mn |
API Access
Coherus Oncology Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();